Chart-Typ:
Zeitraum:
| Privia Health Group, Inc.: Privia Health Reports Second Quarter 2025 Financial Results | Very Strong First Half Performance Across All Key Operating and Financial MetricsImplemented Providers +13.8% and Practice Collections +18.5% compared to 2Q'24Guidance Raised to Above High End of... ► Artikel lesen |
| Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen |
| Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results | All 2024 Operating and Financial Metrics Above High End of Guidance RangesVery strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023Full-year 2024 Net Cash Provided by... ► Artikel lesen |
| Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares | MOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its... ► Artikel lesen |
| Heartflow, Inc. Announces Pricing of Upsized Initial Public Offering | MOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its... ► Artikel lesen |
| HeartFlow Holding, Inc.: New Analysis Published in Nature Medicine Demonstrates Advantages of Nationwide Coronary CTA Strategy with Heartflow FFRCT in Over 90,000 Patients with Coronary Artery Disease | Two-year data from England's National Health Service show improved care efficiency with reduction in unnecessary invasive and noninvasive cardiac tests using CCTA and Heartflow FFRCT versus CCTA aloneMOUNTAIN... ► Artikel lesen |
| Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen |
| Rackspace US, Inc.: Rackspace Technology and Sema4.ai Launch Industry's First Scalable Enterprise AI Agent Solution | Enterprise-ready Solution Bridges the Gap from AI Experimentation to Full-Scale TransformationSAN ANTONIO, June 18, 2025) services and Rackspace's application management expertise with Sema4.ai's advanced... ► Artikel lesen |
| GeneDx Announces Completion of Fabric Genomics Acquisition | Closing unlocks the next phase of genomic medicine, enabling an end-to-end centralized and decentralized model for offering clinically-actionable genomic insights at a global scale
GAITHERSBURG,... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KESTRA MEDICAL TECHNOLOGIES LTD finden Sie auf Wallstreet Online.